Výsledky vyhledávání

Akademický článek

Update on the challenges and recent advances in cancer immunotherapy

Autor: Baronzio G, Parmar G, Shubina IZH, Cassutti V, Giuli S, Ballerini M, Kiselevsky M

Publikováno v: ImmunoTargets and Therapy, Vol 2013, Iss Issue 1, Pp 39-49 (2013)

Gianfranco Baronzio,1 Gurdev Parmar,2 Irina ZH Shubina,3 Valter Cassutti,1 Sergio Giuli,1 Marco Ballerini,1 Mikhail Kiselevsky3 1Centro Medico Demetra: Hyperthermia and Immunity Center, Terni, Italy; 2Integrated Health Clinic, Fort Langley, British C

Externí odkaz: https://doaj.org/article/e28559326cc64c31ab29dc5448e9d068

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Transplantable Murine Tumors in the Studies of Peptide Antitumor Vaccines.

Autor: Ponomarev AV; N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russia., Shubina IZ; N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russia., Sokolova ZA; N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russia., Baryshnikova MA; N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russia., Kosorukov VS; N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.

Publikováno v: Oncology reviews [Oncol Rev] 2024 Jan 08; Vol. 17, pp. 12189. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).

Zobrazit plný text záznamu

Akademický článek

An algorithm for drug discovery based on deep learning with an example of developing a drug for the treatment of lung cancer.

Autor: Chebanov DK; Department of Molecular Biology of Cancer, BioAlg Corp., Covina, CA, United States., Misyurin VA; Department of Molecular Biology of Cancer, BioAlg Corp., Covina, CA, United States., Shubina IZ; The Russian Melanoma Professional Association (Melanoma.PRO), Moscow, Russia.

Publikováno v: Frontiers in bioinformatics [Front Bioinform] 2023 Nov 09; Vol. 3, pp. 1225149. Date of Electronic Publication: 2023 Nov 09 (Print Publication: 2023).

Zobrazit plný text záznamu

Akademický článek

Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment.

Autor: Chikileva IO; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia., Bruter AV; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia., Persiyantseva NA; Research Institute of Carcinogenesis, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia., Zamkova MA; Research Institute of Carcinogenesis, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia., Vlasenko RY; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia., Dolzhikova YI; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia., Shubina IZ; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia., Donenko FV; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia., Lebedinskaya OV; Department of Histology, Embryology and Cytology, EA Vagner Perm State Medical University, 614000 Perm, Russia., Sokolova DV; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia.; Patrice Lumumba Peoples' Friendship University, 117198 Moscow, Russia., Pokrovsky VS; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia.; Patrice Lumumba Peoples' Friendship University, 117198 Moscow, Russia., Fedorova PO; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia.; Microbiology, Virology and Immunology Department, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia.; II Mechnikov Research Institute of Vaccines and Serums, 105064 Moscow, Russia., Ustyuzhanina NE; ND Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia., Anisimova NY; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia., Nifantiev NE; ND Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia., Kiselevskiy MV; Research Institute of Experimental Therapy and Diagnostics of Tumor, NN Blokhin National Medical Center of Oncology, 115478 Moscow, Russia.

Publikováno v: Biomedicines [Biomedicines] 2023 Sep 18; Vol. 11 (9). Date of Electronic Publication: 2023 Sep 18.

Zobrazit plný text záznamu

Akademický článek

Osteoconductive, Osteogenic, and Antipathogenic Plasma Electrolytic Oxidation Coatings on Titanium Implants with BMP-2.

Autor: Popova AD; National University of Science and Technology 'MISIS', Moscow 119049, Russia., Sheveyko AN; National University of Science and Technology 'MISIS', Moscow 119049, Russia., Kuptsov KA; National University of Science and Technology 'MISIS', Moscow 119049, Russia., Advakhova DY; National University of Science and Technology 'MISIS', Moscow 119049, Russia., Karyagina AS; Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Gamaleya Str. 18, Moscow 123098, Russia.; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie gori 1, Str. 40, Moscow 119992, Russia.; All-Russia Research Institute of Agricultural Biotechnology, Russian Academy of Sciences, 127550 Moscow, Russia., Gromov AV; Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Gamaleya Str. 18, Moscow 123098, Russia., Krivozubov MS; Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Gamaleya Str. 18, Moscow 123098, Russia., Orlova PA; Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Gamaleya Str. 18, Moscow 123098, Russia., Volkov AV; The Peoples Friendship University of Russia (RUDN University), Miklukho-Maklaya Str. 6, Moscow 117198, Russia., Slukin PV; State Research Center for Applied Microbiology and Biotechnology, Obolensk 142279, Russia, National University of Science and Technology 'MISIS', Moscow 119049, Russia., Ignatov SG; State Research Center for Applied Microbiology and Biotechnology, Obolensk 142279, Russia, National University of Science and Technology 'MISIS', Moscow 119049, Russia., Shubina IZ; N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, Moscow 115478, Russia., Ilnitskaya AS; N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, Moscow 115478, Russia., Gloushankova NA; N.N. Blokhin National Medical Research Center of Oncology, Kashirskoe Shosse 24, Moscow 115478, Russia., Timoshenko RV; National University of Science and Technology 'MISIS', Moscow 119049, Russia., Erofeev AS; National University of Science and Technology 'MISIS', Moscow 119049, Russia., Shtansky DV; National University of Science and Technology 'MISIS', Moscow 119049, Russia.

Publikováno v: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2023 Aug 09; Vol. 15 (31), pp. 37274-37289. Date of Electronic Publication: 2023 Jul 27.

Zobrazit plný text záznamu

Report

Spontaneous regression of a metastatic carcinoma transmitted by a kidney graft.

Autor: Kiselevskiy MV; Laboratory of Cell Immunity, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow 115552, Russia., Gromova EG; Intensive Care Unit, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow 115552, Russia., Kozlov NA; Pathology Department, Division of Morphological and Molecular Genetic Diagnostics of Tumors, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow 115552, Russia., Bezhanova SD; Pathology Department, Division of Morphological and Molecular Genetic Diagnostics of Tumors, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow 115552, Russia., Shubina IZ; Laboratory of Cell Immunity, N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow 115552, Russia.

Publikováno v: Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2023; Vol. 4 (3), pp. 511-518. Date of Electronic Publication: 2023 Jun 30.

Zobrazit plný text záznamu

Akademický článek

Perspectives for the Use of Fucoidans in Clinical Oncology.

Autor: Kiselevskiy MV; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, 24 Kashirskoe Sh., Moscow 115478, Russia.; Center for Biomedical Engineering, National University of Science and Technology MISIS, Leninsky Prospect 4, Moscow 119049, Russia., Anisimova NY; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, 24 Kashirskoe Sh., Moscow 115478, Russia.; Center for Biomedical Engineering, National University of Science and Technology MISIS, Leninsky Prospect 4, Moscow 119049, Russia., Ustyuzhanina NE; N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Av., 47, Moscow 119991, Russia., Vinnitskiy DZ; N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Av., 47, Moscow 119991, Russia., Tokatly AI; N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Av., 47, Moscow 119991, Russia., Reshetnikova VV; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, 24 Kashirskoe Sh., Moscow 115478, Russia., Chikileva IO; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, 24 Kashirskoe Sh., Moscow 115478, Russia., Shubina IZ; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, 24 Kashirskoe Sh., Moscow 115478, Russia., Kirgizov KI; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, 24 Kashirskoe Sh., Moscow 115478, Russia., Nifantiev NE; N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Av., 47, Moscow 119991, Russia.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Oct 05; Vol. 23 (19). Date of Electronic Publication: 2022 Oct 05.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání